ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,996.66
1.00%
Dow Jones
43,487.83
0.78%
US Dollar vs MXN
20.5534
-1.18%
Brent Oil
79.065
-1.43%
Bitcoin
104,833.80
1.64%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Repare Therapeutics Inc (RPTX) Cotización

Repare Therapeutics Inc

Repare Therapeutics Inc (RPTX)

NASDAQ
1.275
0.005
(0.39%)
Cerrado 20 Enero 3:00PM
Delayed by 15 minutes
1.27
-0.005
(-0.39%)
Fuera de horario: 5:56PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
1.27
Postura de Compra
1.21
Postura de Venta
1.59
Volume Operado de la Acción
236,517
1.26 Rango del Día 1.30
1.20 Rango de 52 semanas 8.49
Capitalización de Mercado [m]
53.989M
Precio Anterior
1.27
Precio de Apertura
1.28
Hora
47000
@
1.27
(formt)
Última hora de negociación
Volumen financiero
US$ 302,038
Precio Promedio Ponderado
1.277
Volumen promedio (3 m)
436,506
Acciones en circulación
42,510,708
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.58
Beneficio por acción (BPA)
-2.21
turnover
51.13M
Beneficio neto
-93.8M

Acerca de Repare Therapeutics Inc

Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability,... Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Using its SNIPRx platform, it is developing pipeline of SL product candidates, including its product candidate, RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.reparerx.com
Sede
Saint-laurent, Quebec, Can
Fundado
-
Repare Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RPTX. The last closing price for Repare Therapeutics was US$1.27. Over the last year, Repare Therapeutics shares have traded in a share price range of US$ 1.20 to US$ 8.49.

Repare Therapeutics currently has 42,510,708 shares in issue. The market capitalisation of Repare Therapeutics is US$53.99 million. Repare Therapeutics has a price to earnings ratio (PE ratio) of -0.58.

RPTX Últimas noticias

Más noticias

Form 8-K - Current report

10 Enero 2025
Edgar (US Regulatory)

Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions

Realigning resources to extend runway to mid-2027 Focus on clinical development of RP-1664 (PLK4 inhibitor) and RP-3467 (Polθ ATPase inhibitor), with initial clinical readouts expected beginning...

09 Enero 2025
Business Wire

Form 8-K - Current report

12 Diciembre 2024
Edgar (US Regulatory)

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial

Heavily-pretreated patients on lunresertib and camonsertib combination achieved 25.9% overall response rate (ORR) in endometrial cancer and 37.5% in platinum-resistant ovarian cancer Nearly half...

12 Diciembre 2024
Business Wire

Repare Therapeutics to Host Webcast to Report Data from the Lunresertib and Camonsertib Combination Phase 1 MYTHIC Clinical Trial

Event to be webcast live on Thursday, December 12 at 4:30 p.m. ET Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today...

10 Diciembre 2024
Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Noviembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Noviembre 2024
Edgar (US Regulatory)

Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced a Cooperative Research and Development Agreement (CRADA...

12 Noviembre 2024
Business Wire

Form 424B5 - Prospectus [Rule 424(b)(5)]

07 Noviembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 Noviembre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.0151.195219123511.2551.441.235388101.33475935CS
4-0.055-4.150943396231.3251.481.25559831.32459418CS
12-2.11-62.4260355033.384.06951.24365062.01909597CS
26-2.53-66.57894736843.84.291.22519422.33690773CS
52-5.13-80.156256.48.491.22219033.24751378CS
156-13.92-91.639236339715.1918.681.22499108.88513786CS
260-30.78-96.037441497732.0546.441.221646913.84182298CS

RPTX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Repare Therapeutics?
El precio actual de las acciones de Repare Therapeutics es US$ 1.27
¿Cuántas acciones de Repare Therapeutics están en circulación?
Repare Therapeutics tiene 42,510,708 acciones en circulación
¿Cuál es la capitalización de mercado de Repare Therapeutics?
La capitalización de mercado de Repare Therapeutics es USD 53.99M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Repare Therapeutics?
Repare Therapeutics ha negociado en un rango de US$ 1.20 a US$ 8.49 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Repare Therapeutics?
El ratio precio/beneficio de Repare Therapeutics es -0.58
¿Cuál es el ratio de efectivo a ventas de Repare Therapeutics?
El ratio de efectivo a ventas de Repare Therapeutics es 1.06
¿Cuál es la moneda de reporte de Repare Therapeutics?
Repare Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Repare Therapeutics?
El último ingresos anual de Repare Therapeutics es USD 51.13M
¿Cuál es el último beneficio anual de Repare Therapeutics?
El último beneficio anual de Repare Therapeutics es USD -93.8M
¿Cuál es la dirección registrada de Repare Therapeutics?
La dirección registrada de Repare Therapeutics es 7210 FREDERICK-BANTING STREET, SUITE 100, SAINT-LAURENT, QUEBEC, H4S 2A1
¿Cuál es la dirección del sitio web de Repare Therapeutics?
La dirección del sitio web de Repare Therapeutics es www.reparerx.com
¿En qué sector industrial opera Repare Therapeutics?
Repare Therapeutics opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

RPTX Discussion

Ver más
glenn1919 glenn1919 4 semanas hace
RPTX....................https://stockcharts.com/h-sc/ui?s=RPTX&p=W&b=5&g=0&id=p86431144783
👍️0
al dean al dean 1 mes hace
Rather odd to say the least. I feel bad for recommending this as a buy. Fast track status means FDA must answer within 60 days. MMs are showing no mercy and much greed ! upside to this will be extreme as well--in my opinion. Good luck !
👍️0
Arnold25764 Arnold25764 1 mes hace
No bottom to this or what?
👍️0
glenn1919 glenn1919 1 mes hace
RPTX............................https://stockcharts.com/h-sc/ui?s=RPTX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 5 meses hace
RPTX under $3
👍️0
Monksdream Monksdream 9 meses hace
RPTX under $5
👍️0
Monksdream Monksdream 1 año hace
From that awful Cathie Wood
Repare Therapeutics (RPTX)
icon-rise-1
17%
Shares of Repare Therapeutics traded up ~17% on Thursday after the company announced10 its second-quarter financial results. During its Research and Development Day in the fourth quarter, management will present updates on the company’s preclinical pipeline and disclose the target for RP-1664. Repare Therapeutics is a precision oncology company searching for novel therapeutics targets by using its discovery platform, SNIPRX.
👍️0
Gator44 Gator44 3 años hace
I believe we going to break 15 on today is close.
👍️0
ElusTrade ElusTrade 3 años hace
I believe we going hit 15 this week if not more....
👍️0
akamaii akamaii 3 años hace
Not alone bought on the news sold Friday 1290 flipped twice and long now again till 20 May flip along the way 15 next the deal is good stuff and the stock is down roche just put a seal of approval
👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: We just busted-through to a "LUCKY THIRTEEN DOLLARS" price!!! NOT quite to the MOON, as they say. But what-the-FLICK, I'll take it!!

👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: Something is UP!!!! INDEED, a shinny-new GREEN COLOR for our --- well, at least MY shares --- of RPTX!! RPTX just might have some UPDATE NEWS coming next Monday, Peeps!! (HA-HA-HA!!!)

👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: GREEN!!!! Green is beautiful!!! "GREEN-STOCKS-MATTER"!!!!!




"And by the way, iHub, I don't give a FLUCK if Morgan Fairchild just turned Sweet-116-Years old!!!!"
👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: Oooooops!!! You MM's can NOT keep our little GREEN-PRICE-Parrot away forever!!! So cut-that-out, you reprobate MM's!!!!

👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: I just LOVE being ALONE over here!! (However, click handy LINK, below, for the "Bee Gees" EPIC ballad with THAT name!!! Maybe the BEST "ballad" ever done!!! Yet I'll wager that NOBODY here as ever even HEARD about this song!!! HA-HA-HA!!!)



👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: Well, good morning, FOLKS!!! (Just trying to get a word in here edgewise is difficult, as you can see! We 'gots' so many POSTS here everyday, the iHub Algorithms simply can't handle the action!! )

In any event, GO-GO-GO-RPTX!!! Take us to the MOON today!! Well, at least maybe to the 'International SPACE STATION??? (HA-HA-HA!!!)

👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: NOT a bad day here.
👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: Hey, 'RA-40' Dude, your post is the BEST point of the DAY about this RPTX-Roche-Company partnership!! Indeed, THAT many SHARES traded at the circa $9-$12 price range is impressive. This Company has nice, BIG, upside PRICE potential. Big-Time-ROCHE didn't cement that HUGE deal today because RPTX is some Stinky-Pinky-Wanna-Be-Big-PHARMA, with scores of USELESS "Patents-Pending"; nor weekly (Elementary School) Petri-Dish-&-Test-Tube-Studies; nor Miraculous-Sick-MICE-Cures!

See-ya tomorrow!!!

👍️0
retireat40 retireat40 3 años hace
No one noticing? Volume was 139 times normal
👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: May have a late-day RUN here, Folks!! Whether anyone likes it, or not!!! (HA-HA-HA!!!)


"Heck, ya never know WHAT-THE-FLUCK is gonna happen on these Stock Market GAMBLING CASINOS these days!!!!"
👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: They WILL notice this little GEM, Dude --- soon enough!!!

https://www.fool.com/investing/2022/06/02/why-repare-therapeutics-stock-is-skyrocketing-toda/
👍️0
ElusTrade ElusTrade 3 años hace
It huge news but no one noticing
👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: Now UP by a glorious 44%, Peeps & Homeboys!!! Don't miss the FUN -- let alone the PROFITS -- via this MONSTER Medical Science play!!! I guess nobody is YET paying any attention to today's NEWS about this little GEM!!! (HA-HA-HA!!!)

https://www.tipranks.com/news/article/2-insiders-hot-stocks-with-growth-potential/

https://finance.yahoo.com/news/repare-therapeutics-announces-worldwide-license-200500192.html

https://seekingalpha.com/news/3844736-rptx-stock-gains-as-roche-signs-licensing-deal-for-tumor-candidate

👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: Ain't gonna be CRICKETS in here for very much longer, Folks!!!!

https://www.tipranks.com/news/article/2-insiders-hot-stocks-with-growth-potential/

https://finance.yahoo.com/news/repare-therapeutics-announces-worldwide-license-200500192.html

https://seekingalpha.com/news/3844736-rptx-stock-gains-as-roche-signs-licensing-deal-for-tumor-candidate

👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: Yet another handy LINK (Fidelity) about this rather NICE news today for RPTX. (HA-HA-HA!!!)
https://eresearch.fidelity.com/eresearch/evaluate/news/basicNewsStory.jhtml?symbols=RPTX&pageno=&storyid=202206011618RTRSNEWSCOMBINED_FWN2XO0QP_1&provider=RTRSNEWS&product=COMBINED&
👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: Welcome aboard, Bro!!! This one is the proverbial, "Biggest No-Brainer In The History Of Mankind" routine!!! (Hey, I DO indeed realize that I am iHub's unoffical 'CLASS CLOWN'; but nevertheless, even FOOLS like me can pick-em ONCE in awhile!! HA-HA-HA!!!)


"Heck, I used to think that the ONLY time in my life that I ever got 'LUCKY', was winning a lousy Two-Dollar-Scratcher for TEN BUCKS in a 7/11-Store back in 1982! But with RPTX, I just hit the MOTHERLODE!!!! Bottom line, finally gettin' some RESPECT!!!!"
👍️0
Laszlo1 Laszlo1 3 años hace
I am in
👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: Ya-all MISSED the take-off!! I am already well on my way to the MOON! Never been there, so it may be interesting!

"This is one small STEP for Mankind; but one GIANT LEAP for the bank account balance of iHub's own JUST-KEEP-TRYING Dude!!!" (HA-HA-HA!!!)

👍️0
Just-Keep-Trying Just-Keep-Trying 3 años hace
RPTX: Anybody gonna join me for a quick trip to the MOON today??? I can fly there all by MYSELF, but it sure gets LONELY way out there; but, I think I can MUSCLE-through-it, nevertheless. (HA-HA-HA!!)

https://www.marketwatch.com/story/roche-repares-licensing-deal-includes-milestone-payments-worth-up-to-12-billion-2022-06-02

https://pulse2.com/repare-therapeutics-rptx-stock-price-why-it-increased-over-20-today/

https://www.postregister.com/businessreport/healthcare/repare-therapeutics-announces-a-worldwide-license-and-collaboration-agreement-with-roche-for-camonsertib-rp-3500/article_a6d38b6f-626d-51f5-a151-9e0e435be816.html

https://www.marketbeat.com/instant-alerts/nasdaq-rptx-a-buy-or-sell-right-now-2022-06/


"Heck, last time I saw a stock like THIS rocketship, it landed on Planet JUPITER by lunchtime on Wall Street!"
👍️0

Su Consulta Reciente

NASDAQ
RPTX
Repare Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados